The office, people and counterparty names on this page are hidden. Create a free account to reveal 5 records a month, or get Family Office Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

M•••••• G••••

Single family office (probable)Top 500

Single family office (probable), with 7 direct investments on record.

Composed from this office's classification, location and record.

Direct investments
7
Deal announcements, Form D and filings
Decision makers
1 of 4
The office's site, Form ADV Schedule A and filings
Last deployment
Jul 2021
The latest dated investment or commitment on record
Contact decision makersFind similar offices
1 export, up to 5 contact reveals
More
As of · the latest observation of this office; filed figures carry their own filing dates

What matters now

  1. Jul 2021
    latest direct deal

    Latest direct deals: I••••••• G••••••• I••• (biotech / gene therapy, seed, $2.5M check, led, Jul 2021), V••••••• B•••••••• I••• (biopharma, led, Apr 2016) and Z•••••••• I••• (biotechnology, Oct 2008). No newer direct deal is on record since 12 Jul 2021.

    What it bought last is the best guide to what it will buy next, and to the check it writes.

    Factannounced deals, press and filingsFor Founders and sponsors raising equityAll direct i•••••••••
Readings, classification basis and verificationidentity confidence 70% · 15 observations · 3 sourcesShow
Single family office (probable)Verified Sep 16, 2026 (7 days ago)4 people · 7 investments · 0 public positions · 9 events

Why this class: a filing by a third party describes it as a single family office (cited).

Direct investing
70
high
Co-investment
40
elevated

Each reading is 0 to 100 from the listed components in the evidence section; hover a tile for what it measures. No evidence yet of: external managers, private markets, sponsor-friendly, real estate.

Profile completeness 47% (high value, high value shallow; the most valuable missing fact is contacts)
identityclassificationwealth origincapital-scale evidencepeoplecontactsmandatedirect investmentsfund relationshipsco-investorssponsor relationshipsreal estatepublic holdingsrecent eventsprovenancefreshness
Overview
show
Classification
Single family office (probable)
Description
••• Locked
Headquarters
unknown
Office address
unknown
Business phone
unknown
Website
unknown
Year established
unknown
Assets under management
unknown
Capital scale
Reported office AUM: unknown. No public number of any kind.
Classification history
  • Sep 14, 2026Single family office (probable) 70%a filing by a third party describes it as a single family office (cited)Fact
  • Sep 14, 2026Candidate 25%no rule matched; held as a candidate pending researchInference
Family and wealth origin
show
Family served
H••• and M••••••••• families; N••• H••• and S••••• M••••••••• are the co-principals of the M•••••• g••••
Source of wealth
••• Locked
Operating company origin
unknown
Team
4 people, 1 with investment decisions, decision makers firstshow
PersonTitleResponsibilityBusiness contactSource
N••• H•••Managing PartnerLeadership · investment decisionsnone on record
sec.gov Fact
N••• H••• familyManaging PartnerLeadership · investment decisionsnone on record
sec.gov Fact
S••••• M••••••••• familyCo-PrincipalLeadership · investment decisionsnone on record
N••• H•••Managing Partner / DirectorLeadershipnone on record
Signals and timeline
9show

Most significant first: what kind of change it is, its size, whose change it is, and how recent. 9 events. 13F position changes are under Public stakes and holdings.

  • Apr 28, 2017Office discovered••• LockedDiscoveryFactsec.gov
  • Sep 14, 2026Classification changed••• Lockedc•••••••••Factno URL
  • Jul 12, 2021Direct investment••• LockedDirect investmentsFactincisivegenetics.com
  • Jul 12, 2021Direct investment••• LockedDirect investmentsFactincisivegenetics.com
  • Apr 1, 2016Direct investment••• LockedDirect investmentsFactsec.gov
Full timeline · 9 events
  • Oct 1, 2008Direct investment••• LockedDirect investmentsFactsec.gov
  • Jan 1, 2008Portfolio exit••• LockedDirect investmentsFactsec.gov
  • Jan 1, 2008Portfolio exit••• LockedDirect investmentsFactsec.gov
  • Jan 1, 2002Direct investment••• LockedDirect investmentsFactsec.gov
Investment mandate
show

••• Locked

Stated (their words, cited)
Sectors
Life sciences and technology investing Fact sec.gov
••• Locked
Invests directly
••• Locked Inference sec.gov
••• Locked
Observed (from the investment record)
States
none Fact
Control
unknown (7) Fact
Sectors
biopharma (1), biotechnology (1), biotech / gene therapy (1), textile fiber technology (1), pharmaceuticals (1) Fact
Subsectors
none Fact
Co investors
H••• F••••• (1) Fact
Asset classes
operating company (6), venture capital (1) Fact
Direct vs fund
Fund: 0 · Direct: 7 · Real estate: 0 Fact
Sponsors backed
none Fact
Investment count
7 Fact
Investment kinds
co-founder, director (3), co-founder, Executive Chairman (1), board directorship (1), seed financing, syndicate lead (1), co-founder, President and Director (1) Fact
First and last deal
Last: 2021-07-12 · First: 2002-01-01 Fact
Lead vs participant
unknown (4), lead (3) Fact
Disclosed check sizes
Max: $2.5M · Min: $2.5M · Count: 1 Fact
••• Locked
Inferred (regulatory shape and team)
Nothing to infer from.
Invests directly
N••• H••• co-founded and directs several operating portfolio companies (V••••••• B••••••••, A•••• T•••••••••, C•••••• S•••••••, C•••••• F•••• T•••••••••) rather than only allocating to funds
Allocates to managers
unknown
Asset classes
unknown
Sectors
Life sciences and technology investing
Geography
unknown
Check size
unknown
Direct investments
7 dealsshow
DateCompanyKindSectorRoleAmountWithSource
Jul 12, 2021I••••••• G••••••• I•••Seed financing, syndicate leadbiotech / gene therapylead$2.5MH••• F••••• (co investor)
••• Locked
Apr 1, 2016V••••••• B•••••••• I•••Co-founder, Executive Chairmanbiopharmaleadunknownnone named
sec.gov Fact
••• Locked
Oct 1, 2008Z•••••••• I•••Board directorshipbiotechnologyunknownunknownnone named
sec.gov Fact
••• Locked
Jan 1, 2002
exit Jan 1, 2008
A•••••• P••••••••• C••••Co-founder, President and Directorpharmaceuticalsleadunknownnone named
sec.gov Fact
••• Locked
Date not disclosedC•••••• F•••• T••••••••• I•••Co-founder, directortextile fiber technologyunknownunknownnone named
sec.gov Fact
••• Locked
Date not disclosedC•••••• S••••••• I•••Co-founder, directorunknownunknownunknownnone named
sec.gov Fact
••• Locked
Date not disclosedA•••• T••••••••• I•••Co-founder, directorunknownunknownunknownnone named
sec.gov Fact
••• Locked
Fund and manager relationships
show
No fund commitment or manager relationship on the record. Commitment amounts are shown only when public.
Public stakes and holdings
show
Form 13F holdings
No 13F filing on the record for this office.
Real estate
show
No documented real estate ownership link. A property is attributed to an office only through a documented control relationship, never from a surname.
Co-investors
1show
CounterpartyKindShared dealsFirst, lastExamplesSource
H••• F•••••organisation1Jul 12, 2021 (historical)I••••••• G••••••• I•••incisivegenetics.com
Independent sponsor relationships
show
No cited relationship to an independent sponsor.
Related entities
show
Sources and evidence
15show

Every observation behind this profile: the value, when it was effective, the source, the quote where there is one, and whether it is a fact, an inference or an estimate. 15 shown.

Score components
Freshness
+100 d••• s•••• t•• n••••• s••••••••• f••• o• a•••••• v••••••••• (6 days)
Contactability
+40 n•••• d••••••••• (••• Locked)
Data confidence
+10 d•••••••••
+10 s••••• m••••••
+10 p•••••
+15 i•••••••••
+15 i••••••••• s•••••• (3 sources)
Active deployment
no components; scored 0
Exists confidence
+30 i••••••••• s•••••• (3 sources)
+30 a•••••••••
Research priority
+15 s••••• f••••• o• f••••• i••••••••• c••••••
+15 d••••• i••••••••• o• r•••••
+2 n• w•••••• k•••• •••••••• w•••• f••• o•••
+0 r••• (172)
Mandate confidence
+70 m•••••• s•••••••• b• o••••••• i•••••••••
+20 s••••• m•••••• o• t•• r•••••
Identity confidence
+70 c••••••••• (••• Locked)
Real estate propensity
no components; scored 0
Co investment propensity
+40 c••••••••• o• t•• r••••• (H••• F•••••; H••• F•••••)
Family identity confidence
+60 w••••• o••••• o• o•••••••• c•••••• o• t•• r•••••
+40 f••••• n•••• (••• Locked)
Private markets propensity
no components; scored 0
Current activity confidence
no components; scored 0
External manager propensity
no components; scored 0
Direct investment propensity
+70 o••••••• d••••• i••••••••• (7 on the record)
Independent sponsor propensity
no components; scored 0
View all 15 observations
FactValueEffectiveSourceClass
Board participation••• Locked
••• Locked
Apr 28, 2017DFX analyst research (General-assisted, every claim URL-cited) sec.govFact
Co invest behavior••• Locked
••• Locked
Jul 12, 2021DFX analyst research (General-assisted, every claim URL-cited) incisivegenetics.comFact
Description••• Locked
••• Locked
Apr 28, 2017DFX analyst research (General-assisted, every claim URL-cited) sec.govFact
Edgar fts discoveryfamily officeApr 28, 2017SEC EDGAR full-text search (a filing sentence that says what an entity is, quoted with its URL) sec.govFact
Family servedH••• and M••••••••• families
••• Locked
n/aDFX analyst research (General-assisted, every claim URL-cited) biospace.comFact
Family served••• Locked
••• Locked
Jul 12, 2021DFX analyst research (General-assisted, every claim URL-cited) incisivegenetics.comFact
Invests directly••• Locked
••• Locked
Apr 28, 2017DFX analyst research (General-assisted, every claim URL-cited) sec.govInference
Liquidity event••• Locked
••• Locked
Apr 28, 2017DFX analyst research (General-assisted, every claim URL-cited) sec.govFact
Office type (stated)Single family officeApr 28, 2017SEC EDGAR full-text search (a filing sentence that says what an entity is, quoted with its URL) sec.govFact
SectorsLife sciences and technology investing
••• Locked
Apr 28, 2017DFX analyst research (General-assisted, every claim URL-cited) sec.govFact
Source of wealth••• Locked
••• Locked
Apr 28, 2017DFX analyst research (General-assisted, every claim URL-cited) sec.govFact
Website searchNot foundSep 21, 2026DFX model output (c••••••••• rules, scores, mandates, matches) no URLInference
Website searchNot foundSep 19, 2026DFX model output (c••••••••• rules, scores, mandates, matches) no URLInference
Website searchNot foundSep 16, 2026DFX model output (c••••••••• rules, scores, mandates, matches) no URLInference
Website searchNot foundSep 14, 2026DFX model output (c••••••••• rules, scores, mandates, matches) no URLInference

Not yet on record: capital scale.